HELLP Syndrome, Preeclampsia
Conditions
Keywords
Preeclampsia, HELLP syndrome, Thrombocytopenia, Maternal mortality
Brief summary
Prospective observational study about progression and regression of biological parameters of HELLP syndrome
Detailed description
Data collection included a comprehensive review of pathological histories, identification of complications based on clinical presentation, daily monitoring of biological parameters, documentation of transfusion events, recording of corticosteroid administration according to gestational age, and detailed reporting of extraction and analgesia techniques.
Interventions
None listed
Sponsors
CHU Mohammed VI Marrakech
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Healthy volunteers
No
Inclusion criteria
* Pregnant women who are admitted to the maternal ICU for a biological HELLP syndrome
Exclusion criteria
* Patients whose biological presentation was attributable to other conditions, such as microangiopathies or leukemia. * Patients who benefited from plasma exchange therapy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Platelets count | Up to 10 days | Platelets count will be monitored daily before and after delivery |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Concentration of Lactate dehydrogenase | Up to 10 days | Monitored daily before and after delivery |
| Concentration of Liver enzymes | Up to 10 days | daily monitoring of alkaline phosphatase, alanine transaminase before and after delivery |
Countries
Morocco
Contacts
STUDY_DIRECTORMeryem Essafti, Assistant Professor
CHU Mohammed VI Marrakech
Outcome results
None listed